Physician profile
Mathilde W Franklin
NPI 1649848250
$3,176.13
in general payments reported to CMS, 2019-2025
7 companies · $1,769 in 2025
The $1,769 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $683 · 2024: $421 · 2025: $1,769.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,613 · Travel and Lodging: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,612.72 |
| Travel and Lodging | $1,260.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,713.40 | 2022-2025 | |
| Alcon Vision LLC | $1,112.92 | 2022-2025 | Clareon, Centurion, Hydrus Microstent |
| Johnson & Johnson Surgical Vision, INC. | $254.28 | 2023 | Tecnis Simplicity, Tecnis Iol |
| Genentech USA, INC. | $28.29 | 2024 | Vabysmo |
| Bausch & Lomb Americas INC. | $26.29 | 2022 | |
| Novo Nordisk INC | $23.66 | 2024 | Rybelsus, Ozempic |
| Carl Zeiss Meditec Cataract Technology INC. | $17.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mathilde Franklin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.